Evidence map›Paper›PMID 28740667›Full record

ArticleJournal of thoracic disease2017

Discordance of physician clinical judgment

Pedro J Marcos, Marcos I Restrepo, Francisco J González-Barcala, Nilam J Soni, Iria Vidal, Pilar Sanjuàn, Diego Llinares, Lucía Ferreira-Gonzalez, Carlos Rábade, Isabel Otero-González and 2 more

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Context factors in clinical decision-making: a scoping review.BMC medical informatics and decision making · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pedro J MarcosServicio de Neumología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Universidade da Coruña (UDC), A Coruña, Spain.
Marcos I RestrepoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, South Texas Veterans Health Care System, Audie L. Murphy VA Hospital, and University of Texas Health Science Center, San Antonio, Texas, USA.
Francisco J González-BarcalaServicio de Neumología, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Nilam J SoniDivision of Pulmonary and Critical Care Medicine, Department of Medicine, South Texas Veterans Health Care System, Audie L. Murphy VA Hospital, and University of Texas Health Science Center, San Antonio, Texas, USA.
Iria VidalServicio de Neumología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Universidade da Coruña (UDC), A Coruña, Spain.
Pilar SanjuànServicio de Neumología, Hospital Universitario Lucus Augusti, Lugo, Spain.
Diego LlinaresServicio de Medicina Interna, Hospital Universitario de A Coruña, A Coruña, Spain.
Lucía Ferreira-GonzalezServicio de Medicina Interna, Hospital Arquitecto Marcide, Area Sanitaria de Ferrol, A Coruña, Spain.
Carlos RábadeServicio de Neumología, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Isabel Otero-GonzálezServicio de Neumología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Universidade da Coruña (UDC), A Coruña, Spain.
Pedro MarcosServicio de Neumología, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
Héctor Verea-HernandoServicio de Neumología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Universidade da Coruña (UDC), A Coruña, Spain.

Funding

Effect of macrolides as immunomodulators in patients with sepsis and pneumoniaK23HL096054 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RESTREPO, MARCOS I. · 2010 to 2014
$689k
NHLBI NIH HHS K23 HL096054
6 · The paper itself

Abstract

backgroundThe relationship between clinical judgment and the pneumonia severity index (PSI) score in deciding the site of care for patients with community-acquired pneumonia (CAP) has not been well investigated. The objective of the study was to determine the clinical factors that influence decision-making to hospitalize low-risk patients (PSI ≤2) with CAP.

methodsAn observational, prospective, multicenter study of consecutive CAP patients was performed at five hospitals in Spain. Patients admitted with CAP and a PSI ≤2 were identified. Admitting physicians completed a patient-specific survey to identify the clinical factors influencing the decision to admit a patient. The reason for admission was categorized into 1 of 6 categories. We also assessed whether the reason for admission was associated with poorer clinical outcomes [intensive care unit (ICU) admission, 30-day mortality or readmission].

resultsOne hundred and fifty-five hospitalized patients were enrolled. Two or more reasons for admission were seen in 94 patients (60.6%), including abnormal clinical test results (60%), signs of clinical deterioration (43.2%), comorbid conditions (28.4%), psychosocial factors (28.4%), suspected H1N1 pneumonia (20.6%), and recent visit to the emergency department (ED) in the past 2 weeks (7.7%). Signs of clinical deterioration and abnormal clinical test results were associated with poorer clinical outcomes (P<0.005).

conclusionsLow-risk patients with CAP and a PSI ≤2 are admitted to the hospital for multiple reasons. Abnormal clinical test results and signs of clinical deterioration are two specific reasons for admission that are associated with poorer clinical outcomes in low risk CAP patients.

Indexed as

Community-acquired pneumonia (CAP)hospitalizationpneumonia severity index (PSI)

Identifiers

PMID28740667
PMCPMC5506170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.